GSK

Showing 15 posts of 760 posts found.

Tyvber image

GSK and Roche get EU breast cancer indication

August 15, 2013
Sales and Marketing GSK, Herceptin, Roche, Tyverb, Xeloda, breast cancer

The European Commission has granted a new indication for the use of GSK’s breast cancer drug Tyverb in combination with …

GSK image

HIV pill Tivicay gains FDA approval

August 14, 2013
Sales and Marketing FDA, GSK, Tivicay, ViiV

ViiV and partner GlaxoSmithKline’s new HIV drug Tivicay has been shown the FDA’s green light for distribution in the US. …

NICE image

AllTrials campaign releases manifesto

August 9, 2013
Medical Communications, Research and Development, Sales and Marketing Bad pharma, GSK, Goldacre, NICE, transparency

The UK clinical trial transparency initiative AllTrials has released its first detailed manifesto as it looks to ramp up pressure …

GSK banks on bioelectronics with new fund

August 9, 2013
Medical Communications, Research and Development, Sales and Marketing Bioelectronics, COPD, GSK, asthma, diabetes

GSK has established a $50 million venture capital fund to invest in the emerging field of bioelectronics. Described as one …

Votrient image

GSK seeks licence extensions

August 8, 2013
Sales and Marketing Cervarix, EMA, GSK, Votrient

GlaxoSmithKline is seeking to extend the licences of two of its brands, Cervarix and Votrient, in a bid to extend …

GSK image

FDA makes GSK wait

August 6, 2013
Sales and Marketing FDA, GSK, albiglutide, diabetes

The FDA is making GlaxoSmithKline wait for a verdict on the manufacturer’s investigational type 2 diabetes treatment albiglutide, extending its …

Tyverb image

GSK loses Tyverb patent

August 6, 2013
Sales and Marketing Cancer, GSK, GlaxoSmithKline, Tyverb

GlaxoSmithKline has received a knockback from authorities in India, who have revoked the patent on its breast cancer drug Tyverb. …

GSK image

Actions in China ‘shameful’ says GSK boss

July 25, 2013
Medical Communications, Sales and Marketing China, GSK, Witty, bribery

GlaxoSmithKline has admitted that allegations of corruption at its China business are ‘shameful’ and will seek out its cause. Speaking …

Benlysta image

Benlysta once again rejected by NICE

July 25, 2013
Sales and Marketing Benlysta, GSK, NHS, NICE

NICE has opened a second public consultation for GSK’s lupus drug Benlysta after the Institute has again rejected the medicine …

gsk image

GSK sales up – impact of China allegations to follow

July 24, 2013
Sales and Marketing GSK, Q2, Seretide, Seroxat, Witty, bribery, transparency

GlaxoSmithKline has reported a modest rise in sales but the fallout from China’s bribery probe dominates the firm’s release of …

AstraZeneca image

AstraZeneca staff questioned in China

July 23, 2013
Medical Communications, Sales and Marketing AstraZeneca, China, GSK, bribery

AstraZeneca says it has no details on the reasons why three of its employees in China have been questioned by …

The Gateway to Local Adoption Series

Latest content